TGA approves use of COVID drug remdesivir

Updated July 11 2020 - 12:11am, first published 12:05am
Remdesivir has been provisionally approved in Australia for treatment of severe cases of COVID-19.
Remdesivir has been provisionally approved in Australia for treatment of severe cases of COVID-19.

The Therapeutic Goods Administration has given provisional approval to a drug that can improve the recovery time of the most seriously ill COVID-19 patients.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Gunnedah news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.